

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.62918977 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.62918977 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.02561694 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.02561694 |
| 5 | detection of other organism (GO:0098543) | 4.97151191 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.91716027 |
| 7 | detection of bacterium (GO:0016045) | 4.84481186 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.77393489 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.48114878 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.48114878 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48114878 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48114878 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48114878 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.48114878 |
| 15 | detection of external biotic stimulus (GO:0098581) | 4.19422979 |
| 16 | positive regulation of interferon-alpha production (GO:0032727) | 4.09797623 |
| 17 | type I interferon signaling pathway (GO:0060337) | 4.07044371 |
| 18 | cellular response to type I interferon (GO:0071357) | 4.07044371 |
| 19 | response to type I interferon (GO:0034340) | 4.05722949 |
| 20 | * immunoglobulin mediated immune response (GO:0016064) | 3.97942278 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.93539158 |
| 22 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.92424423 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.89155798 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 3.86734262 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.74964468 |
| 26 | detection of biotic stimulus (GO:0009595) | 3.69886475 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.66304960 |
| 28 | respiratory burst (GO:0045730) | 3.60586941 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.57405950 |
| 30 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54447924 |
| 31 | * response to peptidoglycan (GO:0032494) | 3.54304179 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.54017471 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51862805 |
| 34 | regulation of T cell tolerance induction (GO:0002664) | 3.49207330 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.39590928 |
| 36 | response to interleukin-15 (GO:0070672) | 3.38749073 |
| 37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.38742409 |
| 38 | regulation of tolerance induction (GO:0002643) | 3.38266326 |
| 39 | leukocyte aggregation (GO:0070486) | 3.37497264 |
| 40 | defense response to protozoan (GO:0042832) | 3.34771224 |
| 41 | microglial cell activation (GO:0001774) | 3.34051789 |
| 42 | response to muramyl dipeptide (GO:0032495) | 3.32207072 |
| 43 | cellular response to interferon-beta (GO:0035458) | 3.31950378 |
| 44 | response to interferon-beta (GO:0035456) | 3.30344705 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 3.30099468 |
| 46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.26393142 |
| 47 | macrophage activation (GO:0042116) | 3.24047814 |
| 48 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24018947 |
| 49 | interferon-gamma production (GO:0032609) | 3.23118353 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22320182 |
| 51 | germinal center formation (GO:0002467) | 3.21728167 |
| 52 | positive regulation of mast cell activation (GO:0033005) | 3.19431883 |
| 53 | polyketide metabolic process (GO:0030638) | 3.19167396 |
| 54 | doxorubicin metabolic process (GO:0044598) | 3.19167396 |
| 55 | daunorubicin metabolic process (GO:0044597) | 3.19167396 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.17534091 |
| 57 | response to interferon-alpha (GO:0035455) | 3.16531789 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.15380260 |
| 59 | regulation of leukocyte degranulation (GO:0043300) | 3.14024768 |
| 60 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.13979042 |
| 61 | negative thymic T cell selection (GO:0045060) | 3.13444761 |
| 62 | response to protozoan (GO:0001562) | 3.12995408 |
| 63 | cellular response to interleukin-15 (GO:0071350) | 3.11630622 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.09235700 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.08106108 |
| 66 | * B cell mediated immunity (GO:0019724) | 3.07964541 |
| 67 | response to host immune response (GO:0052572) | 3.07888086 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.07888086 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.07859960 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07499832 |
| 71 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.07161841 |
| 72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.06406075 |
| 73 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05025484 |
| 74 | regulation of mast cell activation (GO:0033003) | 3.04795489 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 3.04409379 |
| 76 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.04005612 |
| 77 | positive thymic T cell selection (GO:0045059) | 3.03849171 |
| 78 | positive regulation of antigen processing and presentation (GO:0002579) | 3.03732970 |
| 79 | positive regulation of type 2 immune response (GO:0002830) | 3.02130122 |
| 80 | cellular extravasation (GO:0045123) | 3.00872698 |
| 81 | negative T cell selection (GO:0043383) | 3.00635144 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00295779 |
| 83 | negative regulation of innate immune response (GO:0045824) | 3.00197516 |
| 84 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.98305102 |
| 85 | cellular response to exogenous dsRNA (GO:0071360) | 2.97658791 |
| 86 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.96646789 |
| 87 | T cell migration (GO:0072678) | 2.96248959 |
| 88 | NIK/NF-kappaB signaling (GO:0038061) | 2.94846572 |
| 89 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94403177 |
| 90 | reactive oxygen species biosynthetic process (GO:1903409) | 2.93079734 |
| 91 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91206575 |
| 92 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.91144920 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 2.90946418 |
| 94 | negative regulation of interleukin-12 production (GO:0032695) | 2.90399685 |
| 95 | granulocyte activation (GO:0036230) | 2.90363067 |
| 96 | * positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89947118 |
| 97 | positive regulation of mast cell degranulation (GO:0043306) | 2.89868911 |
| 98 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.89868911 |
| 99 | regulation of response to interferon-gamma (GO:0060330) | 2.89792016 |
| 100 | neutrophil mediated immunity (GO:0002446) | 2.89392814 |
| 101 | negative regulation of type 2 immune response (GO:0002829) | 2.88136931 |
| 102 | positive regulation of defense response to virus by host (GO:0002230) | 2.88009240 |
| 103 | myeloid cell activation involved in immune response (GO:0002275) | 2.87737381 |
| 104 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.87367955 |
| 105 | neutrophil activation (GO:0042119) | 2.87285983 |
| 106 | positive regulation of tolerance induction (GO:0002645) | 2.86889273 |
| 107 | natural killer cell mediated immunity (GO:0002228) | 2.86425615 |
| 108 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.86425615 |
| 109 | regulation of type 2 immune response (GO:0002828) | 2.85998700 |
| 110 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.84653585 |
| 111 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.83943581 |
| 112 | regulation of B cell differentiation (GO:0045577) | 2.83102659 |
| 113 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82736328 |
| 114 | negative regulation of phagocytosis (GO:0050765) | 2.82489096 |
| 115 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81612819 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.80312661 |
| 117 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79762535 |
| 118 | response to host (GO:0075136) | 2.79762535 |
| 119 | response to host defenses (GO:0052200) | 2.79762535 |
| 120 | regulation of RIG-I signaling pathway (GO:0039535) | 2.79257907 |
| 121 | negative regulation of viral genome replication (GO:0045071) | 2.78423854 |
| 122 | regulation of antigen processing and presentation (GO:0002577) | 2.77808969 |
| 123 | cellular response to interferon-gamma (GO:0071346) | 2.76955434 |
| 124 | natural killer cell activation (GO:0030101) | 2.75385065 |
| 125 | * regulation of chemokine biosynthetic process (GO:0045073) | 2.74204780 |
| 126 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73826704 |
| 127 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.73653119 |
| 128 | T-helper 1 type immune response (GO:0042088) | 2.73520824 |
| 129 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.73059723 |
| 130 | cellular response to virus (GO:0098586) | 2.72383398 |
| 131 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.71798556 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.71362407 |
| 133 | cellular response to zinc ion (GO:0071294) | 2.69560297 |
| 134 | myeloid dendritic cell activation (GO:0001773) | 2.69547443 |
| 135 | myeloid dendritic cell differentiation (GO:0043011) | 2.69380232 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.68413951 |
| 137 | natural killer cell differentiation (GO:0001779) | 2.64645216 |
| 138 | pinocytosis (GO:0006907) | 2.60913105 |
| 139 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.60608332 |
| 140 | dendritic cell differentiation (GO:0097028) | 2.59370360 |
| 141 | regulation of necroptotic process (GO:0060544) | 2.58789802 |
| 142 | positive regulation of B cell mediated immunity (GO:0002714) | 2.57468683 |
| 143 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.57468683 |
| 144 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.56550830 |
| 145 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.56168155 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.39407562 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.27931692 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.61562936 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.68355686 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40813323 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.91396272 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.89114467 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86619026 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86208765 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75286877 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74226901 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65854621 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.62590404 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57638083 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.44080264 |
| 16 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35402732 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23572487 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14587785 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12079047 |
| 20 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.10369931 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09397238 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07852802 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05054959 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.94915624 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 1.92880954 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.92363475 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92349833 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.91980518 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 1.89758231 |
| 30 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.86044604 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84277286 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82901502 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.76626643 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.75317770 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.72051322 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.67941665 |
| 37 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66502050 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64082974 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.60873545 |
| 40 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.60827635 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.60454655 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57876378 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.53803954 |
| 44 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50282895 |
| 45 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49743100 |
| 46 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45026745 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.44871117 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42220658 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41345910 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.40930372 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40185168 |
| 52 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39695284 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38648686 |
| 54 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.38426652 |
| 55 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.38426652 |
| 56 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.38426652 |
| 57 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36533336 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36174412 |
| 59 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.35571283 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34250197 |
| 61 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33981104 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30045841 |
| 63 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28097949 |
| 64 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25872945 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.24399469 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24067383 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.21343364 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20942835 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20859402 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17051693 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13983247 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13858510 |
| 73 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11381528 |
| 74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08572364 |
| 75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08466460 |
| 76 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08141596 |
| 77 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.07511675 |
| 78 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06482482 |
| 79 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.03309944 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03007094 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02782369 |
| 82 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01698644 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99237048 |
| 84 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98446481 |
| 85 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97599356 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97138105 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97004171 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96205608 |
| 89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95934514 |
| 90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95654695 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94778963 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93992339 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93334896 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93082486 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.92158066 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.91792621 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90876408 |
| 98 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90065463 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89817159 |
| 100 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88071388 |
| 101 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87727895 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87683426 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85841893 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85510537 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85244948 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83598859 |
| 107 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82890282 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82879969 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82506658 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.82072452 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81464247 |
| 112 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80653578 |
| 113 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79822702 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78858474 |
| 115 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.78425604 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.76189527 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75771743 |
| 118 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.75031734 |
| 119 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74744181 |
| 120 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.74035425 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73694612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.07944458 |
| 2 | MP0003436_decreased_susceptibility_to | 3.68119376 |
| 3 | MP0009785_altered_susceptibility_to | 3.58777693 |
| 4 | MP0006082_CNS_inflammation | 2.91952966 |
| 5 | MP0005671_abnormal_response_to | 2.86823596 |
| 6 | MP0000685_abnormal_immune_system | 2.86155555 |
| 7 | MP0003724_increased_susceptibility_to | 2.83239500 |
| 8 | * MP0005000_abnormal_immune_tolerance | 2.81244804 |
| 9 | * MP0005025_abnormal_response_to | 2.76959379 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.74658511 |
| 11 | * MP0005387_immune_system_phenotype | 2.57868447 |
| 12 | * MP0001790_abnormal_immune_system | 2.57868447 |
| 13 | * MP0002419_abnormal_innate_immunity | 2.55443460 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.53478084 |
| 15 | MP0003303_peritoneal_inflammation | 2.45311517 |
| 16 | * MP0002452_abnormal_antigen_presenting | 2.43940774 |
| 17 | * MP0002723_abnormal_immune_serum | 2.37019568 |
| 18 | * MP0001819_abnormal_immune_cell | 2.22906714 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.21662127 |
| 20 | MP0002405_respiratory_system_inflammati | 2.03677271 |
| 21 | MP0001853_heart_inflammation | 1.99899781 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.92906062 |
| 23 | MP0004947_skin_inflammation | 1.89746812 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.89639954 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 1.83703970 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.83302527 |
| 27 | * MP0002398_abnormal_bone_marrow | 1.80884491 |
| 28 | * MP0000716_abnormal_immune_system | 1.77701624 |
| 29 | * MP0001845_abnormal_inflammatory_respons | 1.76959625 |
| 30 | * MP0010155_abnormal_intestine_physiology | 1.76098936 |
| 31 | MP0008260_abnormal_autophagy | 1.74930012 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.70491660 |
| 33 | MP0002396_abnormal_hematopoietic_system | 1.69948206 |
| 34 | MP0002006_tumorigenesis | 1.68972664 |
| 35 | MP0004510_myositis | 1.68191885 |
| 36 | MP0000343_altered_response_to | 1.64059649 |
| 37 | MP0005451_abnormal_body_composition | 1.63448462 |
| 38 | MP0000858_altered_metastatic_potential | 1.60136271 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.60052142 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.59619422 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.59619422 |
| 42 | MP0009278_abnormal_bone_marrow | 1.58494035 |
| 43 | MP0009764_decreased_sensitivity_to | 1.57922167 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.57740604 |
| 45 | MP0003448_altered_tumor_morphology | 1.57129413 |
| 46 | * MP0008469_abnormal_protein_level | 1.55337377 |
| 47 | MP0002722_abnormal_immune_system | 1.54767508 |
| 48 | MP0002254_reproductive_system_inflammat | 1.53627144 |
| 49 | * MP0002429_abnormal_blood_cell | 1.52888323 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.49805832 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.47786144 |
| 52 | MP0003300_gastrointestinal_ulcer | 1.46356019 |
| 53 | MP0005310_abnormal_salivary_gland | 1.31764294 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.28483038 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.26603809 |
| 56 | MP0009840_abnormal_foam_cell | 1.24658785 |
| 57 | MP0000490_abnormal_crypts_of | 1.20836679 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.20681364 |
| 59 | MP0001873_stomach_inflammation | 1.20658354 |
| 60 | MP0003075_altered_response_to | 1.18711997 |
| 61 | MP0003186_abnormal_redox_activity | 1.16926316 |
| 62 | MP0005075_abnormal_melanosome_morpholog | 1.15718132 |
| 63 | MP0004883_abnormal_blood_vessel | 1.14131877 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.11787467 |
| 65 | MP0005023_abnormal_wound_healing | 1.11293986 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.11277788 |
| 67 | MP0003566_abnormal_cell_adhesion | 1.06911137 |
| 68 | MP0002933_joint_inflammation | 1.06117257 |
| 69 | MP0004782_abnormal_surfactant_physiolog | 1.05018932 |
| 70 | MP0005390_skeleton_phenotype | 1.03691836 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.03636250 |
| 72 | MP0000703_abnormal_thymus_morphology | 1.02343711 |
| 73 | MP0008004_abnormal_stomach_pH | 1.02250201 |
| 74 | MP0009763_increased_sensitivity_to | 1.01786037 |
| 75 | MP0002998_abnormal_bone_remodeling | 1.01705002 |
| 76 | MP0003011_delayed_dark_adaptation | 0.95626105 |
| 77 | MP0000604_amyloidosis | 0.95295834 |
| 78 | MP0002277_abnormal_respiratory_mucosa | 0.93934977 |
| 79 | MP0001851_eye_inflammation | 0.93158271 |
| 80 | MP0004381_abnormal_hair_follicle | 0.93138642 |
| 81 | MP0003690_abnormal_glial_cell | 0.89266093 |
| 82 | MP0002019_abnormal_tumor_incidence | 0.86775007 |
| 83 | MP0001663_abnormal_digestive_system | 0.86389182 |
| 84 | MP0005164_abnormal_response_to | 0.86164492 |
| 85 | MP0003828_pulmonary_edema | 0.85506496 |
| 86 | MP0010307_abnormal_tumor_latency | 0.84674455 |
| 87 | MP0005166_decreased_susceptibility_to | 0.83055361 |
| 88 | MP0002132_abnormal_respiratory_system | 0.82463706 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.81066587 |
| 90 | MP0003866_abnormal_defecation | 0.80711640 |
| 91 | MP0004264_abnormal_extraembryonic_tissu | 0.80011181 |
| 92 | MP0000249_abnormal_blood_vessel | 0.76718126 |
| 93 | MP0005257_abnormal_intraocular_pressure | 0.75667553 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.73899850 |
| 95 | MP0002332_abnormal_exercise_endurance | 0.72484781 |
| 96 | MP0000609_abnormal_liver_physiology | 0.72033954 |
| 97 | MP0008057_abnormal_DNA_replication | 0.71683067 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.71311582 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.70859648 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.70785974 |
| 101 | MP0003795_abnormal_bone_structure | 0.70165959 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.70134863 |
| 103 | MP0003045_fibrosis | 0.68881059 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.67751856 |
| 105 | MP0003091_abnormal_cell_migration | 0.65736413 |
| 106 | MP0000598_abnormal_liver_morphology | 0.64746916 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 0.63271787 |
| 108 | MP0008874_decreased_physiological_sensi | 0.63118758 |
| 109 | MP0003279_aneurysm | 0.61783945 |
| 110 | MP0001348_abnormal_lacrimal_gland | 0.59781056 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.59263879 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.57437761 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.56225488 |
| 114 | MP0002139_abnormal_hepatobiliary_system | 0.50935381 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.49143246 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.44825453 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.44614360 |
| 118 | MP0005365_abnormal_bile_salt | 0.43448591 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.42963929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.02687277 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.70736387 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.55236619 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.97845634 |
| 5 | Myositis (HP:0100614) | 4.77713251 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.41965882 |
| 7 | Orchitis (HP:0100796) | 4.14486873 |
| 8 | Autoimmune thrombocytopenia (HP:0001973) | 4.02523628 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.83537517 |
| 10 | Nasal polyposis (HP:0100582) | 3.68031925 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.64979454 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.62091606 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.57202998 |
| 14 | Chronic otitis media (HP:0000389) | 3.53784028 |
| 15 | Recurrent viral infections (HP:0004429) | 3.51895018 |
| 16 | Recurrent skin infections (HP:0001581) | 3.41827173 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.32578987 |
| 18 | Keratoconjunctivitis (HP:0001096) | 3.27588833 |
| 19 | Gingivitis (HP:0000230) | 3.26807383 |
| 20 | Cellulitis (HP:0100658) | 3.18335521 |
| 21 | Petechiae (HP:0000967) | 3.14521059 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.12116739 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 3.03518941 |
| 24 | * Vasculitis (HP:0002633) | 3.02454262 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00972557 |
| 26 | Obstructive lung disease (HP:0006536) | 3.00972557 |
| 27 | Recurrent bronchitis (HP:0002837) | 2.96914878 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 2.88480611 |
| 29 | Optic neuritis (HP:0100653) | 2.88480611 |
| 30 | Pustule (HP:0200039) | 2.87895062 |
| 31 | Peritonitis (HP:0002586) | 2.87382427 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 2.86913236 |
| 33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.86913236 |
| 34 | Periodontitis (HP:0000704) | 2.83601146 |
| 35 | Stomatitis (HP:0010280) | 2.80796225 |
| 36 | Leukocytosis (HP:0001974) | 2.74368258 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.72446228 |
| 38 | Multiple enchondromatosis (HP:0005701) | 2.70873728 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.70749863 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.70749863 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.70749863 |
| 42 | Episodic fever (HP:0001954) | 2.70154320 |
| 43 | Thrombocytosis (HP:0001894) | 2.66296633 |
| 44 | Meningitis (HP:0001287) | 2.64504197 |
| 45 | Pulmonary embolism (HP:0002204) | 2.64272106 |
| 46 | Loss of speech (HP:0002371) | 2.62749439 |
| 47 | Gangrene (HP:0100758) | 2.61777728 |
| 48 | Abnormality of T cells (HP:0002843) | 2.61496004 |
| 49 | Increased cerebral lipofuscin (HP:0011813) | 2.60619535 |
| 50 | IgM deficiency (HP:0002850) | 2.59362237 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55702422 |
| 52 | Reduced antithrombin III activity (HP:0001976) | 2.51919939 |
| 53 | Hemoptysis (HP:0002105) | 2.51868451 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.50932119 |
| 55 | Basal ganglia calcification (HP:0002135) | 2.50021409 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.49354734 |
| 57 | * Gingival bleeding (HP:0000225) | 2.48741290 |
| 58 | Cheilitis (HP:0100825) | 2.48315338 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.47925996 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.43614721 |
| 61 | Combined immunodeficiency (HP:0005387) | 2.40783212 |
| 62 | Poor head control (HP:0002421) | 2.39167500 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.38841752 |
| 64 | T lymphocytopenia (HP:0005403) | 2.37631335 |
| 65 | Chest pain (HP:0100749) | 2.36387598 |
| 66 | * Anorexia (HP:0002039) | 2.34413608 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.33829396 |
| 68 | Eosinophilia (HP:0001880) | 2.32264688 |
| 69 | * Pulmonary infiltrates (HP:0002113) | 2.30113616 |
| 70 | Sepsis (HP:0100806) | 2.27626485 |
| 71 | Increased serum ferritin (HP:0003281) | 2.25595165 |
| 72 | Abnormality of the peritoneum (HP:0002585) | 2.24838702 |
| 73 | Hepatosplenomegaly (HP:0001433) | 2.24686513 |
| 74 | Purpura (HP:0000979) | 2.24251130 |
| 75 | * Hypergammaglobulinemia (HP:0010702) | 2.22813757 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.21260473 |
| 77 | * Urticaria (HP:0001025) | 2.19500929 |
| 78 | Osteomyelitis (HP:0002754) | 2.19497040 |
| 79 | Glomerulopathy (HP:0100820) | 2.19470249 |
| 80 | Arterial thrombosis (HP:0004420) | 2.18932268 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.16059845 |
| 82 | Increased IgE level (HP:0003212) | 2.16053452 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.14238714 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.12643507 |
| 85 | Granulocytopenia (HP:0001913) | 2.11796957 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.11507310 |
| 87 | Amyloidosis (HP:0011034) | 2.09271430 |
| 88 | Axonal loss (HP:0003447) | 2.09158571 |
| 89 | Skin rash (HP:0000988) | 2.05760980 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05217806 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.04343847 |
| 92 | Lymphopenia (HP:0001888) | 2.04068243 |
| 93 | * Skin ulcer (HP:0200042) | 2.03840981 |
| 94 | * Increased IgM level (HP:0003496) | 2.03572648 |
| 95 | Colitis (HP:0002583) | 2.03385396 |
| 96 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03132895 |
| 97 | Abnormality of the pericardium (HP:0001697) | 2.03053494 |
| 98 | * Epistaxis (HP:0000421) | 2.02047494 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.01732079 |
| 100 | Osteolytic defects of the hand bones (HP:0009699) | 2.01271266 |
| 101 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01271266 |
| 102 | Microcytic anemia (HP:0001935) | 1.99566383 |
| 103 | Emphysema (HP:0002097) | 1.98115775 |
| 104 | Vertebral compression fractures (HP:0002953) | 1.98069820 |
| 105 | Acne (HP:0001061) | 1.97510875 |
| 106 | Prolonged bleeding time (HP:0003010) | 1.96827465 |
| 107 | Encephalitis (HP:0002383) | 1.96025630 |
| 108 | Joint swelling (HP:0001386) | 1.95763295 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.95573620 |
| 110 | Hypochromic anemia (HP:0001931) | 1.95370440 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.94816038 |
| 112 | Abnormality of eosinophils (HP:0001879) | 1.93318890 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.93127445 |
| 114 | Myocardial infarction (HP:0001658) | 1.92321855 |
| 115 | Restrictive lung disease (HP:0002091) | 1.91617114 |
| 116 | * Abnormality of the pleura (HP:0002103) | 1.90685713 |
| 117 | Tetraparesis (HP:0002273) | 1.90604089 |
| 118 | Hypertensive crisis (HP:0100735) | 1.90584182 |
| 119 | Acute hepatic failure (HP:0006554) | 1.90147348 |
| 120 | Hematochezia (HP:0002573) | 1.90095593 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.90040100 |
| 122 | Arthralgia (HP:0002829) | 1.89747044 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.89727813 |
| 124 | Amaurosis fugax (HP:0100576) | 1.87958204 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.61762044 |
| 2 | MAP4K1 | 3.38597743 |
| 3 | TBK1 | 2.82778223 |
| 4 | MAP3K14 | 2.74039942 |
| 5 | TYK2 | 2.71512441 |
| 6 | BLK | 2.69825047 |
| 7 | PRPF4B | 2.66275106 |
| 8 | CDK12 | 2.47327774 |
| 9 | TXK | 2.35727784 |
| 10 | KIT | 2.35013395 |
| 11 | TGFBR2 | 2.34509876 |
| 12 | JAK3 | 2.31549745 |
| 13 | IKBKE | 2.27787091 |
| 14 | CSF1R | 2.27014572 |
| 15 | ZAP70 | 2.26755127 |
| 16 | GRK6 | 2.22024499 |
| 17 | STK10 | 2.17615021 |
| 18 | IRAK4 | 2.14084897 |
| 19 | IKBKB | 1.95113585 |
| 20 | TNK2 | 1.82745997 |
| 21 | CSK | 1.79015601 |
| 22 | PIM2 | 1.75840587 |
| 23 | FGR | 1.65447669 |
| 24 | TAOK3 | 1.59617541 |
| 25 | BTK | 1.58630707 |
| 26 | FGFR4 | 1.58421591 |
| 27 | RIPK4 | 1.57957810 |
| 28 | IRAK3 | 1.54512769 |
| 29 | MATK | 1.50561854 |
| 30 | SIK3 | 1.50541623 |
| 31 | JAK1 | 1.50020608 |
| 32 | NME2 | 1.46735092 |
| 33 | SYK | 1.35004695 |
| 34 | EPHB1 | 1.33280967 |
| 35 | TEC | 1.33244169 |
| 36 | BMPR2 | 1.31982667 |
| 37 | MAP2K3 | 1.28957098 |
| 38 | KDR | 1.26979631 |
| 39 | ADRBK2 | 1.23565632 |
| 40 | HCK | 1.22668455 |
| 41 | RPS6KA4 | 1.21368553 |
| 42 | FGFR3 | 1.20752448 |
| 43 | ITK | 1.20496737 |
| 44 | MAP3K1 | 1.16689763 |
| 45 | FLT3 | 1.16488806 |
| 46 | TESK2 | 1.12642225 |
| 47 | LCK | 1.11121786 |
| 48 | CHUK | 1.09449426 |
| 49 | GRK5 | 1.08579369 |
| 50 | RIPK1 | 1.00223189 |
| 51 | GRK1 | 0.98957204 |
| 52 | MAP3K10 | 0.98297814 |
| 53 | LRRK2 | 0.97994206 |
| 54 | MOS | 0.96966846 |
| 55 | LYN | 0.95789664 |
| 56 | TRIB3 | 0.93529998 |
| 57 | MST4 | 0.92055681 |
| 58 | MAP3K3 | 0.91979718 |
| 59 | PIM1 | 0.90968043 |
| 60 | PRKG2 | 0.89336523 |
| 61 | GRK7 | 0.88349203 |
| 62 | JAK2 | 0.87453800 |
| 63 | PRKD2 | 0.85247186 |
| 64 | YES1 | 0.80779325 |
| 65 | PAK4 | 0.79803802 |
| 66 | MAP3K13 | 0.77106807 |
| 67 | EPHA3 | 0.76518446 |
| 68 | CDC42BPA | 0.76226465 |
| 69 | KSR2 | 0.75693740 |
| 70 | PDK1 | 0.74866746 |
| 71 | EIF2AK2 | 0.74627161 |
| 72 | NLK | 0.73374346 |
| 73 | IRAK2 | 0.70946625 |
| 74 | NEK9 | 0.70818605 |
| 75 | PDPK1 | 0.69788657 |
| 76 | SMG1 | 0.68128361 |
| 77 | CLK1 | 0.67562228 |
| 78 | MAP3K11 | 0.67486945 |
| 79 | MARK2 | 0.66997626 |
| 80 | TESK1 | 0.64443695 |
| 81 | PBK | 0.64239425 |
| 82 | SIK1 | 0.64064339 |
| 83 | PIK3CG | 0.62008892 |
| 84 | FYN | 0.60965856 |
| 85 | SIK2 | 0.60100261 |
| 86 | FES | 0.57991691 |
| 87 | MAP3K6 | 0.55489537 |
| 88 | PRKCD | 0.54042561 |
| 89 | BMX | 0.51265655 |
| 90 | MAPK7 | 0.50877657 |
| 91 | MAP3K5 | 0.50015241 |
| 92 | STK4 | 0.49662795 |
| 93 | MAPK12 | 0.48604106 |
| 94 | ABL2 | 0.48309981 |
| 95 | MAPKAPK2 | 0.47149501 |
| 96 | HIPK2 | 0.47020999 |
| 97 | ABL1 | 0.46574001 |
| 98 | CDK19 | 0.45493228 |
| 99 | MARK3 | 0.43874670 |
| 100 | PKN2 | 0.41248740 |
| 101 | RPS6KL1 | 0.40960589 |
| 102 | RPS6KC1 | 0.40960589 |
| 103 | TGFBR1 | 0.40736002 |
| 104 | DYRK1B | 0.40367140 |
| 105 | IGF1R | 0.36467262 |
| 106 | MAPKAPK3 | 0.35861018 |
| 107 | TTN | 0.34962101 |
| 108 | CDK7 | 0.34632110 |
| 109 | PTK2B | 0.34291496 |
| 110 | CDK4 | 0.32949724 |
| 111 | EEF2K | 0.32942308 |
| 112 | TRPM7 | 0.32820177 |
| 113 | EGFR | 0.32503314 |
| 114 | MAP2K2 | 0.32311721 |
| 115 | MAP3K7 | 0.31912868 |
| 116 | TIE1 | 0.31370116 |
| 117 | MAP2K6 | 0.31163962 |
| 118 | MAP3K8 | 0.31148846 |
| 119 | PTK6 | 0.31130650 |
| 120 | MAPK4 | 0.30410898 |
| 121 | MAPK11 | 0.30013651 |
| 122 | RPS6KA6 | 0.29307929 |
| 123 | ALK | 0.28789192 |
| 124 | TAOK1 | 0.28059763 |
| 125 | IRAK1 | 0.27846487 |
| 126 | TAOK2 | 0.27767109 |
| 127 | PRKCQ | 0.26641324 |
| 128 | RET | 0.24095277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.98142333 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.59820846 |
| 3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53664444 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.49353332 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.48093307 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38815474 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30677709 |
| 8 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29055836 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.26913224 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26911311 |
| 11 | * Measles_Homo sapiens_hsa05162 | 2.19751088 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10826294 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.09631248 |
| 14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07439525 |
| 15 | * Legionellosis_Homo sapiens_hsa05134 | 2.05844490 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.86650109 |
| 17 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.84669986 |
| 18 | * Malaria_Homo sapiens_hsa05144 | 1.79813536 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.78293896 |
| 20 | * Influenza A_Homo sapiens_hsa05164 | 1.74063667 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.73826835 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.70475903 |
| 23 | * Pertussis_Homo sapiens_hsa05133 | 1.69244408 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63809930 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.62333913 |
| 26 | * Tuberculosis_Homo sapiens_hsa05152 | 1.55367067 |
| 27 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.51624150 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48834235 |
| 29 | Asthma_Homo sapiens_hsa05310 | 1.48425109 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.45279607 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.44153299 |
| 32 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40871935 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.35083481 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.32217871 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.31157280 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29912016 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24266717 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17146518 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15948531 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15871131 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15673468 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.15237154 |
| 43 | * Salmonella infection_Homo sapiens_hsa05132 | 1.13199130 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12398414 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 1.10798398 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08789116 |
| 47 | * Hepatitis B_Homo sapiens_hsa05161 | 1.04619568 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03247042 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01900724 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97267543 |
| 51 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.96513884 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90910687 |
| 53 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87517559 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86595380 |
| 55 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86121211 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.85757380 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82787721 |
| 58 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82528683 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79011101 |
| 60 | DNA replication_Homo sapiens_hsa03030 | 0.78403661 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75130143 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73312229 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72720679 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70971455 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69274971 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68322751 |
| 67 | Ribosome_Homo sapiens_hsa03010 | 0.68065241 |
| 68 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66979762 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.65386742 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65170550 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65146685 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65052732 |
| 73 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65051159 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.64649055 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64604361 |
| 76 | Amoebiasis_Homo sapiens_hsa05146 | 0.64120329 |
| 77 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63817393 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.60277965 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58786613 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.58208101 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57497714 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55848698 |
| 83 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55548115 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53637792 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50231082 |
| 86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48381951 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48376628 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46725004 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.43502330 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42161402 |
| 91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41782460 |
| 92 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41506974 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39468967 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39272862 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39048426 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37430296 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.36263074 |
| 98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35627979 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34965414 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34944177 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34493637 |
| 102 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34422641 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34062783 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32292604 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31110329 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31037366 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.30233947 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.30081080 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29549973 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28019975 |
| 111 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27293861 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.25744132 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.25221123 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.25134680 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24826201 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.23690975 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22962174 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.22345299 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.22279067 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22265165 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21141002 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20398952 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19992165 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19733681 |

